Pharmaceutical Executive-02-01-2008

Pharmaceutical Executive
From the Editor

February 01, 2008

New from Pharm Exec: a blog, expanded tech and deals coverage, and a new awards program for emerging pharma leaders

Pharmaceutical Executive

Global marketing strategies and the business opportunities in Japan

Column
Pharmaceutical Executive

February 01, 2008

With sales forces shrinking, how does the industry combine new technologies with old-fashioned face time to maximize sales?

Pharmaceutical Executive
Washington Report

February 01, 2008

Congress blocked DTC user fees, Reagan-Udall, field force reforms while slightly bumping FDA's budget

Pharmaceutical Executive

A black-box warning needn't spell doom for your product. Here's how to take the good with the bad and end up on top.

Pharmaceutical Executive

Will the sole-wholesaler approach mean higher costs for NHS?

Pharmaceutical Executive
Features

February 01, 2008

With Chantix, Pfizer combined inspired drug design with innovative customer-focused marketing to make the first real medical assault on nicotine addiction.

Pharmaceutical Executive

Can pharma take its talent-and its earning potential-to the next level with employee education?

Pharmaceutical Executive

Novartis and Cadient served up a very successful unbranded campaign on YouTube. Pharma should take note of this Web 2.0 victory.

Pharmaceutical Executive
Features

February 01, 2008

US officials think they can control MRSA and other "superbugs," but dangerous bacteria know no boundaries. What does the world do when its drugs stop working?

Pharmaceutical Executive
Features

February 01, 2008

Many say licensing is the new R&D. We've rounded up the unions to watch from the third quarter of 2007.